Spliceosome SRSF2 mutations are the second most common alterations of the splicing factor in MDS [2] and are observed mainly in association with MDS characterized by multilineage dysplasia and are considered predictors of unfavorable prognosis and a high risk of AML transformation [40]. This evidence concerns the gene SRSF2 and acute myeloid leukemia.